Abarceo Pharma AB

Malmö, Skåne, Sweden

https://www.abarceo.com

Company profile

Abarceo Pharma AB company profile

Abarceo Pharma is a spin out of Lund University Diabetes Center and is located in Malmo Sweden. Scientific founders Prof. Claes Wollheim, MD and Associate Prof. Albert Salehi are world-class experts in beta cell biology. Abarceo Pharma is a Lund University Holding company and was founded in December 2017. The company is dedicated to developing novel therapeutics for type-2 diabetes based upon a deep molecular and genetic understanding of the disease.

Business identity

Website: https://www.abarceo.com
Operating status: Active
Company type: For Profit
Employee range: 00001-00010 employees
Revenue range: $1K+
Founded: 2017-01-01

Headquarters

Headquarters: Malmö, Skåne, Sweden
Postal code: 205 12
Country code: SE
Continent: Europe

Capital profile

Funding and company signals

Funding rounds: 1
Total equity funding: $2.6M
Last funding: Series Unknown / $2.6M / 2021-03-01
Last equity funding: Series Unknown / $2.6M
Investors: 2
Lead investors: 1
Founders: 1
Articles: 1

Categories and groups

Biotechnology Pharmaceutical Therapeutics Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Tara Heitner

Lead investors

Almi Invest

Investors

Almi InvestLU Innovation

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.